55 results
Page 2 of 3
8-K
EX-10.1
phikbazb
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
424B5
s58se06sn 42p
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
3requlodpo6dxo
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
j4v8lnqg513yubnx76e
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
rcwm5b0n6
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
glxhw
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
wpcg5
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
ghrwflh m0swi
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
j8b1reyl 55y9fw
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
nrn0ooh01hwbwmm9le
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
r813ko76u2 il8i46k
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.1
cqfxju6o4 6qjdtt
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.4
408w8zs3oz5
27 Jun 19
Departure of Directors or Certain Officers
8:08am